Raymond James在Encompass Health Co. (EHC)案的股份增加到7.8%,而Q2 EPS案的股份比共识高出0.10美元。 Raymond James increased stake in Encompass Health Co. (EHC) to 7.8%, and Q2 EPS beat consensus by $0.10.

雷蒙德·詹姆斯及其他机构投资者在第二季度增加了对恩康普斯健康公司 (NYSE: EHC) 的股权,雷蒙德·詹姆斯购买了9701股,占7.8%的股权. Raymond James & Associates and other institutional investors increased their stakes in Encompass Health Co. (NYSE: EHC) in Q2, with Raymond James buying 9,701 shares, resulting in a 7.8% position. Encompass Health报告,Q2 EPS为1.11美元,比协商一致的估计数高出0.10美元,并宣布季度红利为0.17美元。 Encompass Health reported Q2 EPS of $1.11, beating the consensus estimate by $0.10, and announced a $0.17 quarterly dividend. 包括斯蒂芬斯、巴克莱斯和UBS集团在内的各公司的分析师给予该公司购买或购买评级很高或非常高。 Analysts from various firms, including Stephens, Barclays, and UBS Group, have given the company a buy or strong buy rating.